phase readout
saveNCT03328026: Combination Study of SV-BR-1-GM With Retifanlimab
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: BriaCell Therapeutics Corporation. Phase: PHASE1. Conditions: Breast Cancer, Breast Neoplasm, Metastatic Breast Cancer, Breast Cancer Metastatic
view source ↗
comments(0)
5-min edit window · permanent after that